EUVIMEDEUVIMED entdecken
Open Access · CC BY-SA 4.0

Variasi Genetik APOA5 rs662799 dalam Metabolisme Trigliserida dan Obesitas Sentral: Sebuah Tinjauan Naratif

Nazilh Rizky Nandhita Lubis, Anggelia Puspasari, Hasna Dewi, Citra Maharani, Mara Imam Taufiq Siregar, Esa Indah Ayudia

Vitalitas Medis : Jurnal Kesehatan dan Kedokteran · 31.07.2026 · 3 (3) · 323-337

DOI: 10.62383/vimed.v3i3.3365 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Vitalitas Medis : Jurnal Kesehatan dan Kedokteran, online erschienen am 31.07.2026. Verfasst von Nazilh Rizky Nandhita Lubis und 5 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-SA 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Apolipoprotein A-5 (APOA5) is a hepatic regulator of triglyceride-rich lipoprotein metabolism, and the promoter polymorphism rs662799 is its most extensively investigated variant. This narrative review synthesises current evidence on the molecular consequences of rs662799 and its relationship with lipid profile, central obesity, and metabolic syndrome, with particular attention to its relevance for Asian and Indonesian populations. Literature published between 2011 and 2026 was retrieved from PubMed, ScienceDirect, SpringerLink, Google Scholar, and Garuda, and thirty-nine sources met the selection criteria. The minor allele reduces promoter transcriptional activity, lowers APOA5 concentration, and impairs lipoprotein lipase-mediated triglyceride clearance, resulting in higher plasma triglyceride and lower high-density lipoprotein cholesterol. Meta-analyses report a 1.3- to 1.5-fold increase in metabolic syndrome risk among minor allele carriers, whereas associations with central obesity are inconsistent and frequently conditional on energy intake, sex, or degree of adiposity. Minor allele frequency is substantially higher in East Asian than in European populations, indicating population-specific clinical implications. Evidence relating this variant to lipid-lowering pharmacotherapy response remains scarce and warrants investigation, particularly in Indonesia where population data are still limited.

Zitieren

APA

Lubis, N. R. N., Puspasari, A., Dewi, H., Maharani, C., Siregar, M. I. T., & Ayudia, E. I. (2026). Variasi Genetik APOA5 rs662799 dalam Metabolisme Trigliserida dan Obesitas Sentral: Sebuah Tinjauan Naratif. Vitalitas Medis : Jurnal Kesehatan dan Kedokteran, 3(3), 323-337. https://doi.org/10.62383/vimed.v3i3.3365

Vancouver

Lubis NRN, Puspasari A, Dewi H, Maharani C, Siregar MIT, Ayudia EI. Variasi Genetik APOA5 rs662799 dalam Metabolisme Trigliserida dan Obesitas Sentral: Sebuah Tinjauan Naratif. Vitalitas Medis : Jurnal Kesehatan dan Kedokteran. 2026;3(3):323-337. doi:10.62383/vimed.v3i3.3365

BibTeX
@article{Lubis2026,
  author = {Lubis, Nazilh Rizky Nandhita and Puspasari, Anggelia and Dewi, Hasna and Maharani, Citra and Siregar, Mara Imam Taufiq and Ayudia, Esa Indah},
  title = {Variasi Genetik APOA5 rs662799 dalam Metabolisme Trigliserida dan Obesitas Sentral: Sebuah Tinjauan Naratif},
  journal = {Vitalitas Medis : Jurnal Kesehatan dan Kedokteran},
  year = {2026},
  volume = {3},
  number = {3},
  pages = {323--337},
  doi = {10.62383/vimed.v3i3.3365}
}
Kostenlos starten →